David A Socks's Net Worth
$342 Thousand
Who is David A Socks?
David A Socks does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., HilleVax, Inc., and CADENCE PHARMACEUTICALS INC.
SEC CIK
David A Socks's CIK is 0001378847
Past Insider Trading and Trends
2023 was David A Socks's most active year for acquiring shares with 2 total transactions. David A Socks's most active month to acquire stocks was the month of April. 2024 was David A Socks's most active year for disposing of shares, totalling 1 transactions. David A Socks's most active month to dispose stocks was the month of April. 2023 saw David A Socks paying a total of $0.00 for 24,000 shares, this is the most they've acquired in one year. In 2024 David A Socks cashed out on 17,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55
President, CEO, Treas. & Sec.David A Socks owns 19,500 units of Common Stock which is worth $342,225.00. From 2019 to 2024 David A Socks acquired a total of 19,500 shares in Phathom Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +116.67% | 10.5K |
—
|
—
| 19.5K |
May 23
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| -1.46% | -18.00K |
$32.58 | -$586,395.12 | 1.21M |
Scheduled
|
Oct 7 - Oct 8
| ||
Form 4
| -1.44% | -18.00K |
$32.63 | -$587,350.68 | 1.23M |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
| -1.42% | -18.00K |
$31.25 | -$562,538.16 | 1.25M |
Scheduled
|
Aug 16
| ||
Form 4
| -3.07% | -40.00K |
$34.05 | -$1,361,941.24 | 1.26M |
Scheduled
|
Jun 28 - Jun 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| -2.98% | -40.00K |
$32.64 | -$1,305,505.61 | 1.3M |
Scheduled
|
May 19 - May 20
| ||
Form 4
| -2.90% | -40.00K |
$36.55 | -$1,462,088.84 | 1.34M |
Scheduled
|
Apr 5 - Apr 6
| ||
Form 4
| -3.83% | -55.00K |
$47.58 | -$2,617,090.16 | 1.38M |
Scheduled
|
Mar 10 - Mar 12
| ||
Form 4
| -4.65% | -70.00K |
$46.49 | -$3,254,612.12 | 1.44M |
Scheduled
|
Feb 19 - Feb 23
| ||
Form 4
| -2.54% | -40.00K |
$35.70 | -$1,428,037.94 | 1.53M |
Scheduled
|
Jan 11 - Jan 12
| ||
Form 4
| -4.82% | -79.66K |
$43.42 | -$3,458,895.77 | 1.57M |
Scheduled
|
Dec 16 - Dec 17
| ||
Form 4
| -0.91% | -30.34K |
$40.53 | -$1,253,198.14 | 3.32M |
Scheduled
|
Nov 9 - Nov 11
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HilleVax, Inc. (HLVX) Snapshot price: $1.71
CFO & Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CADENCE PHARMACEUTICALS INC No price found
VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||